137 related articles for article (PubMed ID: 3555770)
21. Experimental and clinical activity of mitomycin C and cis-diamminedichloroplatinum in malignant mesothelioma.
Chahinian AP; Norton L; Holland JF; Szrajer L; Hart RD
Cancer Res; 1984 Apr; 44(4):1688-92. PubMed ID: 6423278
[TBL] [Abstract][Full Text] [Related]
22. [Establishment and characteristics of orthotopically transplanted model of human primary malignant small intestinal lymphoma in nude mice].
Liu QZ; Tuo CW; Zhang N; Wang MY
Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):461-4. PubMed ID: 15555333
[TBL] [Abstract][Full Text] [Related]
23. Malignant pleural mesothelioma-targeted CREBBP/EP300 inhibitory protein 1 promoter system for gene therapy and virotherapy.
Fukazawa T; Matsuoka J; Naomoto Y; Maeda Y; Durbin ML; Tanaka N
Cancer Res; 2008 Sep; 68(17):7120-9. PubMed ID: 18757427
[TBL] [Abstract][Full Text] [Related]
24. Increased fatty acid synthase is a therapeutic target in mesothelioma.
Gabrielson EW; Pinn ML; Testa JR; Kuhajda FP
Clin Cancer Res; 2001 Jan; 7(1):153-7. PubMed ID: 11205903
[TBL] [Abstract][Full Text] [Related]
25. Interferon gamma is highly effective against orthotopically-implanted human pleural adenocarcinoma in nude mice.
An Z; Wang X; Astoul P; Danays T; Moossa AR; Hoffman RM
Anticancer Res; 1996; 16(5A):2545-51. PubMed ID: 8917349
[TBL] [Abstract][Full Text] [Related]
26. In vitro characteristics of a human mammary carcinoma prior to and after transplantation into nude mice.
Nissen E; Arnold W; Weiss H; Naundorf H; Tanneberger S
Acta Histochem Suppl; 1983; 27():179-83. PubMed ID: 6408693
[TBL] [Abstract][Full Text] [Related]
27. Establishment of in vivo fluorescence imaging in mouse models of malignant mesothelioma.
Yamaoka N; Kawasaki Y; Xu Y; Yamamoto H; Terada N; Okamura H; Kubo S
Int J Oncol; 2010 Aug; 37(2):273-9. PubMed ID: 20596654
[TBL] [Abstract][Full Text] [Related]
28. Characterization of a human ovarian carcinoma cell line: UCI 101.
Fuchtner C; Emma DA; Manetta A; Gamboa G; Bernstein R; Liao SY
Gynecol Oncol; 1993 Feb; 48(2):203-9. PubMed ID: 8428692
[TBL] [Abstract][Full Text] [Related]
29. [A case of malignant mesothelioma of the pleura and the peritoneum detected by sudden onset of back pain and pleural effusion and ascites].
Yamaguchi K; Naitoh S; Nomura S
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Sep; 35(9):996-1002. PubMed ID: 9396260
[TBL] [Abstract][Full Text] [Related]
30. [Establishment and characteristics of orthotopically transplanted model of human primary malignant spleen lymphoma in nude mice].
Liu Q; Zhao W; Tuo C; Wang Z; Wu B; Zhang N
Zhonghua Zhong Liu Za Zhi; 2002 May; 24(3):234-8. PubMed ID: 12515614
[TBL] [Abstract][Full Text] [Related]
31. [Establishment of a human esophageal carcinoma transplantation model with MUC1 high expression in nude mice].
Deng YJ; Rong TH; Zhou J; Song HF; Wang QJ; Huang LX; Chen SP; Li YQ; Xia JC
Ai Zheng; 2007 Jul; 26(7):693-7. PubMed ID: 17626742
[TBL] [Abstract][Full Text] [Related]
32. Knockdown of COPA, identified by loss-of-function screen, induces apoptosis and suppresses tumor growth in mesothelioma mouse model.
Sudo H; Tsuji AB; Sugyo A; Kohda M; Sogawa C; Yoshida C; Harada YN; Hino O; Saga T
Genomics; 2010 Apr; 95(4):210-6. PubMed ID: 20153416
[TBL] [Abstract][Full Text] [Related]
33. Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice.
Bénard J; Da Silva J; De Blois MC; Boyer P; Duvillard P; Chiric E; Riou G
Cancer Res; 1985 Oct; 45(10):4970-9. PubMed ID: 3861241
[TBL] [Abstract][Full Text] [Related]
34. Biological characterization of cells derived from a human breast carcinoma. I. Some characteristics of cells cultivated in vitro prior to and after transplantation into nude mice.
Nissen E; Arnold W; Weiss H; Görlich M; Elbe B; Naundorf H; Tanneberger S
Arch Geschwulstforsch; 1982; 52(1):17-27. PubMed ID: 7082129
[TBL] [Abstract][Full Text] [Related]
35. Enzymic composition and growth rate of human pleural mesothelioma transplants in nude mice.
Head JF; Chahinian AP; Greengard O
Cancer Biochem Biophys; 1991 Aug; 12(2):127-36. PubMed ID: 1769009
[TBL] [Abstract][Full Text] [Related]
36. 9p21 Deletion in the diagnosis of malignant mesothelioma in serous effusions additional to immunocytochemistry, DNA-ICM, and AgNOR analysis.
Onofre FB; Onofre AS; Pomjanski N; Buckstegge B; Grote HJ; Böcking A
Cancer; 2008 Jun; 114(3):204-15. PubMed ID: 18306350
[TBL] [Abstract][Full Text] [Related]
37. A patient-like human malignant pleural mesothelioma nude-mouse model.
Astoul P; Wang X; Colt H; Boutin C; Hoffman R
Oncol Rep; 1996 May; 3(3):483-7. PubMed ID: 21594397
[TBL] [Abstract][Full Text] [Related]
38. Pathologic evaluation of malignant pleural mesothelioma.
Chirieac LR; Corson JM
Semin Thorac Cardiovasc Surg; 2009; 21(2):121-4. PubMed ID: 19822283
[TBL] [Abstract][Full Text] [Related]
39. Re-expression of p16INK4a in mesothelioma cells results in cell cycle arrest, cell death, tumor suppression and tumor regression.
Frizelle SP; Grim J; Zhou J; Gupta P; Curiel DT; Geradts J; Kratzke RA
Oncogene; 1998 Jun; 16(24):3087-95. PubMed ID: 9671387
[TBL] [Abstract][Full Text] [Related]
40. A novel small-molecule inhibitor of transforming growth factor beta type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection.
Suzuki E; Kim S; Cheung HK; Corbley MJ; Zhang X; Sun L; Shan F; Singh J; Lee WC; Albelda SM; Ling LE
Cancer Res; 2007 Mar; 67(5):2351-9. PubMed ID: 17332368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
